ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,431.60
      -0.04%
      US Tech 100
      19,168.00
      0.52%
      Dow Jones
      38,589.16
      -0.15%
      Brent Oil
      82.275
      0.00%
      Bitcoin
      66,586.69
      0.60%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Transgene S.A. ADS (MM) (TRGNY)

      7. Transgene S.A. ADS (MM) (TRGNY) News

      TRGNY

      Transgene . (TRGNY)

      Transgene S.A. ADS (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:TRGNY
      DateTimeSourceHeadlineSymbolCompany
      10/19/20052:00AMPR Newswire (US)Transgene : Cash Position and Net Cash Expenditures as of September 30, 2005NASDAQ:TRGNY
      09/21/20051:01AMPR Newswire (US)Transgene to Voluntarily Delist From NasdaqNASDAQ:TRGNY
      08/03/20051:01AMPR Newswire (US)Transgene Announces First Half 2005 Financial ResultsNASDAQ:TRGNY
      07/21/20051:01AMPR Newswire (US)Transgene Announces Achievement of Clinical Milestone by Merck & Co., Inc. Using Transgene's Proprietary TechnologyNASDAQ:TRGNY
      07/11/20051:01PMPR Newswire (US)Transgene Raises Euro 34.9 MillionNASDAQ:TRGNY
      05/20/20051:01AMPR Newswire (US)Transgene Announces 20-F Form FilingNASDAQ:TRGNY
      05/17/20051:01AMPR Newswire (US)Transgene's Therapeutic Vaccine MVA-MUC1-IL2 at ASCO:NASDAQ:TRGNY
      05/16/20051:01AMPR Newswire (US)Transgene Presents Updated Positive Phase II Data of Its Therapeutic Vaccine MVA-MUC1-IL2 In Prostate Cancer at Annual ASCO MeetNASDAQ:TRGNY
      04/26/20051:01AMPR Newswire (US)Transgene to Present at the 2nd Rodman & Renshaw Annual Global Healthcare ConferenceNASDAQ:TRGNY
      04/13/20051:01AMPR Newswire (US)Transgene: Cash Position and Net Cash Expenditures as of March 31, 2005NASDAQ:TRGNY
      04/05/20051:01AMPR Newswire (US)Transgene to Present Phase II Data of Its MVA-UC1-IL2 Cancer Vaccine at ASCO's 2005 Annual MeetingNASDAQ:TRGNY
      02/23/20051:00AMPR Newswire (US)Transgene Announces Fiscal Year 2004 Financial ResultsNASDAQ:TRGNY
      02/23/20051:00AMPR Newswire (US)Transgene: New Strategy in Therapeutic Vaccines, MVA-Muc1-IL2 Meets Primary Endpoint in Lung Cancer Phase IINASDAQ:TRGNY
      02/15/200512:01AMPR Newswire (US)Transgene Appoints Jean-Yves Bonnefoy as New Chief Scientific OfficerNASDAQ:TRGNY
      12/08/200412:01AMPR Newswire (US)Transgene Appoints Philippe Archinard As New Chief Executive OfficerNASDAQ:TRGNY
      11/30/200411:34AMPR Newswire (US)Transgene Moves Forward Its Vaccine Candidate MVA-HPV-IL2 In A Novel Approach Against Pre-Cancerous Cervical LesionsNASDAQ:TRGNY
      11/03/200412:01AMPR Newswire (US)Transgene: Cash Position and Net Cash Expenditures as of September 30, 2004NASDAQ:TRGNY
      08/04/20041:01AMPR Newswire (US)Transgene Announces Second Quarter and First Half 2004 Financial ResultsNASDAQ:TRGNY
      07/01/20049:31AMPR Newswire (US)Transgene Manufactures Clinical Lots of HIV Vaccine Candidates for the EUROVAC ProjectNASDAQ:TRGNY
      06/15/20042:00AMPR Newswire (US)Merial and Transgene Sign a Collaboration Agreement to Develop Products for Animal HealthNASDAQ:TRGNYTransgene S.A. ADS (MM)
      06/15/20041:01AMPR Newswire (US)Merial and Transgene Sign a Collaboration Agreement to Develop Products for Animal HealthNASDAQ:TRGNY
      06/08/20041:01AMPR Newswire (US)Transgene Presents Data on MVA-MUC1-IL2 Cancer Vaccine at ASCO and ASGT Annual MeetingsNASDAQ:TRGNY
      05/12/20049:45AMPR Newswire (US)Transgene to Present Data at 2004 ASCO Annual MeetingNASDAQ:TRGNY
      05/05/20041:01AMPR Newswire (US)Transgene Announces First Quarter 2004 Financial ResultsNASDAQ:TRGNY
      04/14/20041:01AMPR Newswire (US)Transgene: Data Presented at The American Association of Cancer Research Annual Meeting Suggest Significant Opportunities for AnNASDAQ:TRGNY
      03/18/200412:01AMPR Newswire (US)Transgene's MVA-HPV-IL2 Vaccine Shows Activity in Phase II Clinical TrialNASDAQ:TRGNY
      02/11/200412:01AMPR Newswire (US)Transgene Announces Fourth Quarter and Fiscal Year 2003 Financial ResultsNASDAQ:TRGNY
      02/09/200412:00AMPR Newswire (US)Transgene Reports Positive Interim Phase II Data from MVA-Muc1-IL2 Cancer Vaccine ProgramNASDAQ:TRGNY
      11/05/200312:01AMPR Newswire (US)Transgene Announces Third Quarter 2003 Financial ResultsNASDAQ:TRGNY
      11/03/200312:01AMPR Newswire (US)Transgene Signs Pre-Clinical AIDS Vaccine Manufacturing Agreement With ANRS and INSERMNASDAQ:TRGNY
       Showing the most relevant articles for your search:NASDAQ:TRGNY